Lilly(Eli) & Co

NYSE:LLY  
230.04
-1.00 (-0.43%)
4:00:00 PM EDT: $229.97 -0.07 (-0.03%)
Products

U.S. FDA Approves Jardiance To Treat Adults Living With Heart Failure With Reduced Ejection Fraction

Published: 08/18/2021 17:36 GMT
Lilly(Eli) & Co (LLY) - Us FDA Approves Jardiance® (empagliflozin) to Treat Adults Living With Heart Failure With Reduced Ejection Fraction.